AquaBounty Technologies, Inc. AQB

Company Overview

AquaBounty Technologies, Inc. was a biotechnology and aquaculture company focused on the development of genetically engineered Atlantic salmon designed to grow faster than conventional salmon. The company operated in the aquaculture and agricultural biotechnology industries, with its primary commercial product being AquAdvantage salmon, a genetically modified Atlantic salmon developed to reach market size more quickly than traditional farmed salmon. Revenue generation historically centered on salmon egg production, fish sales, and aquaculture farming operations, although the company remained in a development and scale-up phase for much of its operating history.

The company was founded in 1991 and became widely known for receiving U.S. Food and Drug Administration approval for AquAdvantage salmon in 2015, marking the first genetically engineered animal approved for human consumption in the United States. AquaBounty positioned itself as a land-based aquaculture operator utilizing recirculating aquaculture systems (RAS), which were intended to reduce reliance on ocean net-pen farming and improve biosecurity and environmental control. Public filings and market disclosures indicate the company pursued a vertically integrated strategy combining biotechnology, fish breeding, and controlled-environment aquaculture production.